Smac Mimetic Increases Chemotherapy Response and Improves Survival in Mice With Pancreatic Cancer

Cancer Research - United States
doi 10.1158/0008-5472.can-09-3892
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Association for Cancer Research (AACR)

Related search

Smac Mimetic-Derived Augmentation of Chemotherapeutic Response in Experimental Pancreatic Cancer

BMC Cancer
Cancer ResearchOncologyGenetics
2011English

Multiagent Neoadjuvant Chemotherapy and Tumor Response Are Associated With Improved Survival in Pancreatic Cancer

HPB
HepatologyGastroenterology
2019English

Adding Chemotherapy Improves Survival in Cervical Cancer

BMJ
1999English

Inhibition of Group 1 P21-Activated Kinases Suppresses Pancreatic Stellate Cell Activation and Increases Survival of Mice With Pancreatic Cancer

International Journal of Cancer
Cancer ResearchOncology
2017English

Survival in Advanced Breast Cancer Combination Chemotherapy Improves Outlook

BMJ
1994English

Sustained CA19-9 Response to Neoadjuvant Chemotherapy in Borderline Resectable Pancreatic Cancer Predicts Progression and Survival

Oncologist
Cancer ResearchMedicineOncology
2020English

Combined Chemotherapy and Radiation Improves Survival for Node-Positive Endometrial Cancer

Gynecologic Oncology
GynecologyOncologyObstetrics
2012English

Investigational Drug Combined With Chemotherapy Improves Response in Patients With BRCA -Mutant Breast Cancer

Cancer
Cancer ResearchOncology
2017English

General Anesthesia Delays the Inflammatory Response and Increases Survival for Mice With Endotoxic Shock

Clinical and Vaccine Immunology
MedicineImmunologyAllergyClinical BiochemistryMicrobiology
2006English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy